Safety Extension Study of TRO19622 in ALS

NCT01285583 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

271

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: TRO19622

Sponsor

Hoffmann-La Roche